Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Bayer brands
Estradiol/drospirenone
Другие языки:

    Estradiol/drospirenone

    Подписчиков: 0, рейтинг: 0
    Estradiol/drospirenone
    Estradiol.svg
    Estradiol
    Drospirenone.svg
    Drospirenone
    Combination of
    Estradiol Estrogen
    Drospirenone Progestogen; Progestin; Antimineralocorticoid; Antiandrogen
    Clinical data
    Trade names Angeliq
    Other names E2/DRSP; BAY-864891
    Routes of
    administration    		 By mouth
    Drug class Estrogen; Progestin; Progestogen; Antimineralocorticoid; Antiandrogen
    Legal status
    Legal status
    Identifiers
    CAS Number

    Estradiol/drospirenone (E2/DRSP), sold under the brand name Angeliq, is a combination of estradiol (E2), an estrogen, and drospirenone (DRSP), a progestin, antimineralocorticoid, and antiandrogen, which is used in menopausal hormone therapy, specifically the treatment of menopausal syndrome and osteoporosis, in postmenopausal women. It is taken by mouth and contains 0.5 to 1 mg E2 and 0.25 to 0.5 mg DRSP per tablet. The medication was approved in the United States in 2005. It is marketed widely throughout the world.

    See also

    External links



    Новое сообщение